No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenine / analogs & derivatives
-
Agammaglobulinaemia Tyrosine Kinase
-
Antineoplastic Agents / pharmacology*
-
Apoptosis / drug effects
-
Benzamides / pharmacology
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Cell Line, Tumor
-
G1 Phase Cell Cycle Checkpoints / drug effects
-
Gene Expression Regulation, Leukemic*
-
Humans
-
Leukemia, Myeloid, Acute / enzymology
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / pathology
-
Molecular Targeted Therapy
-
Organ Specificity
-
Phosphorylation / drug effects
-
Piperidines
-
Protein Kinase Inhibitors / pharmacology*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics
-
Protein-Tyrosine Kinases / metabolism
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / genetics
-
Proto-Oncogene Proteins c-akt / metabolism
-
Pyrazoles / pharmacology*
-
Pyrimidines / pharmacology*
-
STAT5 Transcription Factor / antagonists & inhibitors
-
STAT5 Transcription Factor / genetics
-
STAT5 Transcription Factor / metabolism
-
Signal Transduction
-
fms-Like Tyrosine Kinase 3 / antagonists & inhibitors*
-
fms-Like Tyrosine Kinase 3 / genetics
-
fms-Like Tyrosine Kinase 3 / metabolism
Substances
-
Antineoplastic Agents
-
Benzamides
-
Bridged Bicyclo Compounds, Heterocyclic
-
CGI 1746
-
Piperidines
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyrimidines
-
STAT5 Transcription Factor
-
ibrutinib
-
FLT3 protein, human
-
Protein-Tyrosine Kinases
-
fms-Like Tyrosine Kinase 3
-
Agammaglobulinaemia Tyrosine Kinase
-
Proto-Oncogene Proteins c-akt
-
Adenine